VM

VHCP Management Portfolio holdings

AUM $93M
This Quarter Return
+20.1%
1 Year Return
-10.46%
3 Year Return
+232.85%
5 Year Return
10 Year Return
AUM
$390M
AUM Growth
+$390M
Cap. Flow
-$23.5M
Cap. Flow %
-6.03%
Top 10 Hldgs %
86.28%
Holding
21
New
3
Increased
Reduced
1
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ANAC
1
DELISTED
ANACOR PHARMACEUTICALS INC COM
ANAC
$139M 35.56% 1,178,474
GWPH
2
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$28.5M 7.31% 311,853
HRTX icon
3
Heron Therapeutics
HRTX
$207M
$26.7M 6.85% 1,095,734
RGNX icon
4
Regenxbio
RGNX
$451M
$20.2M 5.17% +1,083,454 New +$20.2M
CHRS icon
5
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$17.4M 4.47% 870,269
LRMR icon
6
Larimar Therapeutics
LRMR
$310M
$17.3M 4.44% 541,480
LPCN icon
7
Lipocine
LPCN
$15.8M
$15M 3.85% 1,269,921
ASND icon
8
Ascendis Pharma
ASND
$11.8B
$14.4M 3.68% 811,152
AKTX
9
Akari Therapeutics
AKTX
$24.8M
$12.7M 3.25% +527,842 New +$12.7M
ADVM icon
10
Adverum Biotechnologies
ADVM
$64.6M
$11.4M 2.92% 1,382,735
ARCT icon
11
Arcturus Therapeutics
ARCT
$462M
$9.06M 2.32% 1,500,000
AVDL
12
Avadel Pharmaceuticals
AVDL
$1.43B
$8.16M 2.09% 500,000
ORKA
13
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
$7.65M 1.96% 1,541,331 -9,247,993 -86% -$45.9M
SRRA
14
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$5.13M 1.32% +250,000 New +$5.13M
STML
15
DELISTED
Stemline Therapeutics, Inc.
STML
$3.99M 1.02% 451,400
OCRX
16
DELISTED
Ocera Therapeutics, Inc.
OCRX
$2.22M 0.57% 703,730
BCRX icon
17
BioCryst Pharmaceuticals
BCRX
$1.74B
-373,686 Closed -$5.58M
JUNO
18
DELISTED
Juno Therapeutics, Inc.
JUNO
-90,206 Closed -$4.81M
ZSPH
19
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
-100,000 Closed -$5.24M